Completed OBSERVATIONAL NCT05556564
The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study
Sponsor: PeriPharm
Conditions
Migraine
Interventions
observational study
Updated 4 times since 2022 Last updated: Apr 19, 2023 Started: Oct 31, 2022 Primary completion: Mar 6, 2023 Completion: Mar 6, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Migraine and is currently completed. PeriPharm leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
Status: Not Yet Recruiting → Completed
-
Sep 2022 — May 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- PeriPharm
Data source: PeriPharm
For direct contact, visit the study record on ClinicalTrials.gov .